
Nutex Health Inc
NASDAQ:NUTX

Intrinsic Value
The intrinsic value of one
NUTX
stock under the Base Case scenario is
220.76
USD.
Compared to the current market price of 176.21 USD,
Nutex Health Inc
is
Undervalued by 20%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Nutex Health Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Nutex Health Inc
Balance Sheet Decomposition
Nutex Health Inc
Current Assets | 292.5m |
Cash & Short-Term Investments | 43.6m |
Receivables | 236.1m |
Other Current Assets | 12.8m |
Non-Current Assets | 362.8m |
PP&E | 324.7m |
Intangibles | 29.4m |
Other Non-Current Assets | 8.7m |
Free Cash Flow Analysis
Nutex Health Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Nutex Health Inc
Revenue
|
479.9m
USD
|
Cost of Revenue
|
-283.7m
USD
|
Gross Profit
|
196.3m
USD
|
Operating Expenses
|
-58.6m
USD
|
Operating Income
|
137.7m
USD
|
Other Expenses
|
-85.5m
USD
|
Net Income
|
52.2m
USD
|
NUTX Profitability Score
Profitability Due Diligence
Nutex Health Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Score
Nutex Health Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
NUTX Solvency Score
Solvency Due Diligence
Nutex Health Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Score
Nutex Health Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NUTX Price Targets Summary
Nutex Health Inc
According to Wall Street analysts, the average 1-year price target for
NUTX
is 104.04 USD
with a low forecast of 56.56 USD and a high forecast of 157.5 USD.
Dividends
Current shareholder yield for NUTX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NUTX
stock under the Base Case scenario is
220.76
USD.
Compared to the current market price of 176.21 USD,
Nutex Health Inc
is
Undervalued by 20%.